Anand Mehta to Hepatitis B virus
This is a "connection" page, showing publications Anand Mehta has written about Hepatitis B virus.
Connection Strength
0.892
-
A ubiquitin independent degradation pathway utilized by a hepatitis B virus envelope protein to limit antigen presentation. PLoS One. 2011; 6(9):e24477.
Score: 0.391
-
alpha-Glucosidase inhibitors have a prolonged antiviral effect against hepatitis B virus through the sustained inhibition of the large and middle envelope glycoproteins. Antivir Chem Chemother. 2006; 17(5):259-67.
Score: 0.263
-
Glucosidase inhibition enhances presentation of de-N-glycosylated hepatitis B virus epitopes by major histocompatibility complex class I in vitro and in woodchucks. Hepatology. 2010 Oct; 52(4):1242-50.
Score: 0.091
-
alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses. Antimicrob Agents Chemother. 2004 Jun; 48(6):2085-90.
Score: 0.059
-
Hepatitis B virus-mediated changes of apolipoprotein mRNA abundance in cultured hepatoma cells. J Virol. 2003 May; 77(9):5503-6.
Score: 0.055
-
Inhibition of cellular alpha-glucosidases results in increased presentation of hepatitis B virus glycoprotein-derived peptides by MHC class I. Virology. 2009 Feb 05; 384(1):12-5.
Score: 0.020
-
Molecular viral oncology of hepatocellular carcinoma. Oncogene. 2003 Aug 11; 22(33):5093-107.
Score: 0.014